Atypical presentation of serious pelvic inflammatory disease following mifepristone-induced medical abortion.
Mifepristone-induced abortion is increasingly common. Recent alerts have highlighted the occurrence of infrequent but serious complications. We report a case of serious bacterial infection after medical termination that occurred in the absence of the usual signs of infection.
Department of Primary Care and General Practice, Wellington School of Medicine and Health Sciences, PO Box 7343, Wellington South, New Zealand. bevlawton@wnmeds.ac.nz
Beverley A
BA
Lawton
Sally B
SB
Rose
Jill
J
Shepherd
D000028:Abortion, Induced / Q000009:adverse effects* / Q000379:methods; D000328:Adult; D000701:Analgesics, Opioid / Q000008:administration & dosage; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D005260:Female; D006069:Gonorrhea / Q000150:complications / Q000188:drug therapy; D006801:Humans; D007958:Leukocyte Count; D015735:Mifepristone / Q000008:administration & dosage / Q000009:adverse effects*; D009344:Neisseria gonorrhoeae / Q000302:isolation & purification; D000292:Pelvic Inflammatory Disease / Q000188:drug therapy / Q000209:etiology* / Q000382:microbiology; D011247:Pregnancy; D013290:Streptococcal Infections / Q000188:drug therapy; D013610:Tachycardia
D000701:Analgesics, Opioid; D000900:Anti-Bacterial Agents; D015735:Mifepristone